G01N 2333/4704
Inhibitors
Official title: Inhibitors; Supressors
G01N2333/4704 (Inhibitors) appears on 154 US grants and 316 published applications in this corpus.
Search patents in G01N- Granted patents
- 154
- Published applications
- 316
- Assignees
- 218
- Inventors
- 658
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 4 | 2 |
| 2002 | 2 | 3 |
| 2003 | 3 | 7 |
| 2004 | 0 | 3 |
| 2005 | 1 | 10 |
| 2006 | 6 | 3 |
| 2007 | 2 | 15 |
| 2008 | 2 | 9 |
| 2009 | 3 | 10 |
| 2010 | 3 | 8 |
| 2011 | 7 | 16 |
| 2012 | 4 | 10 |
| 2013 | 4 | 12 |
| 2014 | 8 | 7 |
| 2015 | 11 | 36 |
| 2016 | 13 | 35 |
| 2017 | 12 | 14 |
| 2018 | 11 | 19 |
| 2019 | 7 | 14 |
| 2020 | 11 | 9 |
| 2021 | 11 | 14 |
| 2022 | 5 | 12 |
| 2023 | 4 | 11 |
| 2024 | 6 | 13 |
| 2025 | 9 | 14 |
| 2026 | 3 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Diagnostic and drug screening for molecular signatures of early onset sporadic parkinson's disease18 Aug 2026US 12,708,611 B2Cedars-Sinai Medical Center
- PKC pathway in Parkinson's Disease3 Mar 2026US 12,564,568 B2Cedars-Sinai Medical Center
- CTHRC1-specific antibody and use thereof6 Jan 2026US 12,516,110 B2Prestige Biopharma Idc Co., Ltd
- Nucleic acid biomarker and use thereof16 Dec 2025US 12,497,666 B2Amgen Inc.
- Composition for prevention or treatment of intractable epilepsy comprising mTOR inhibitor28 Oct 2025US 12,453,733 B2SoVarGen Co., Ltd.
- Assay system13 Aug 2026US 2026/0235632 A1Actome GmbH
- Kit for measuring symmetric dimethylarginine and method for measuring symmetric dimethylarginine30 Jul 2026US 2026/0219262 A1FUJIFILM Corporation
- Materials and methods for quantifying precursor tamm-horsfall protein25 Jun 2026US 2026/0177545 A1
- Otic progenitor cell surface markers18 Jun 2026US 2026/0167930 A1WDI 2 ApS
- Biomarkers in long-covid-199 Apr 2026US 2026/0098868 A1London Health Sciences Centre Research Inc.
Most cited
By later US patents
- Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors127US 7,078,180 B2The Children’s Hospital of Philadelphia · 2006
- Methods for determining isolated p27 protein levels and uses thereof115US 6,316,208 B1Fred Hutchinson Cancer Research Center · 2001
- Marker associated with non-alcoholic steatohepatitis95US 9,060,981 B2Mochida Pharmaceutical Co., Ltd. · 2015
- Antibodies specific for sclerostin and methods of screening and use therefor55US 7,381,409 B2Celltech R&D Limited · 2008
- Immunogenic peptides derived from sclerostin44US 7,868,134 B2UCB Manufacturing, Inc. · 2011